You are here

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019

Planned Enrollment targets achieved in both TRILOGY studies with over 74% of patients randomized at more than 150 clinical sites
Thursday, February 14, 2019 - 08:05